MOBILE, Ala., July 11, 2011 /PRNewswire/ -- HASCO Medical, Inc. (OTCBB: HASC), www.mysouthernmed.com, a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, announced today that Mike Dumais has been named Vice President of Sales for Southern Medical and Mobility, a subsidiary of HASCO Medical Inc.
Most recently Mike was the SVP of sales and operations at eLayaway.com, a business services, listing and alternative payments processor where he devised and implemented a revenue strategy that allowed the company to go public. Prior to that, he was the VP of Sales for AWay2Give & Pay Inc. where he remains a director, advising Non-Profits. Mike was also the Divisional Sales Director of CompUSA where he was primarily responsible for B2B and Small/Medium Business Sales.
Hal Compton, CEO of HASCO Medical, states, "We are pleased to welcome Mike to the Southern Medical and Mobility team. Mike's extensive background and expertise in driving and developing sales teams will be a great asset for the Company as we continue to grow."
About HASCO Medical, Inc.
HASCO Medical ("HASC" or the Company) provides products and services that dramatically improve the quality of living for its customers. The Company's products and services include the sale of durable medical equipment, home respiratory equipment and the sale or rental of wheelchair accessible vans for which it provides custom conversion services. The Company operates in the South Eastern portion of the United States including Alabama, Mississippi and Florida. The Company's objective is to be a leading provider of home health care products and services in the continental United States. For more information on Mobility Freedom, please visit www.mobilityfreedom.com.
This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify those so-called "forward looking statements" by words such as "may," "will," "should," "expects," "plans," "targets," "believes," "anticipates," "estimates," "predicts," "potential," or "continue" or the negative of those words and other comparable words. These forward looking statements are subject to risks and uncertainties, product tests, commercialization risks, availability of financing and results of financing efforts that could cause actual results to differ materially from historical results or those anticipated. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC, which are available on its website at: http://www.sec.gov. We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.
|SOURCE HASCO Medical, Inc.|
Copyright©2010 PR Newswire.
All rights reserved